Top Markets
#1 Akedo Akedo +57.68%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.31%
#4 Cross Cross +43.97%
#5 OVERTAKE OVERTAKE +34.90%
#6 Black Phoenix Black Phoenix +34.01%
#7 Velvet Velvet +27.53%
#8 Cap Cap +15.60%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.31%
#10 Palladium Network Palladium Network +12.56%
Coin of the day
Akedo Akedo
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Kedudukan dalam Saham #39100
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Harga Saham
$0.02243487
Disegerakkan terakhir: 2025-06-04
Modal Pasaran
$650.09K
Perubahan (1 hari)
0.39%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Lipidor AB (publ) (LIPI)

Kategori

Healthcare
Hasil untuk Lipidor AB (publ) (LIPI)
Hasil pada Dec 2024 TTM: $265.61K
Menurut laporan kewangan terkini daripada Lipidor AB (publ), hasil semasa syarikat (TTM) ialah $265.61K. Pada tahun 2023, syarikat memperoleh hasil sebanyak $7.73K peningkatan berbanding hasil pada tahun 2022 iaitu $4.32K. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Lipidor AB (publ) dari 2016 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $265.61K 20,825.07%
2024 $1.27K -83.58%
2023 $7.73K 79.16%
2022 $4.32K -99.75%
2021 $1.70M 2,164.63%
2020 $75.02K 872.70%
2019 $7.71K -71.64%
2018 $27.20K -32.61%
2017 $40.36K 30.11%
2016 $31.02K 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B 29,992,925.40%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B 36,868,756.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B 24,240,300.94%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B 29,184,513.78%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B 24,998,542.91%
US